This site is intended for UK healthcare professionals

 

Heart failure

Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Watch Dermot Neely and Paul Hamilton discuss the different biological lipid transport pathways, how we measure lipids in the blood and how to distinguish between beneficial and non-beneficial lipids, and the national guidelines for lipid management in primary and secondary prevention of cardiovascular disease.
Watch Ahmet Fuat and Maggie Simpson discuss the recent guidelines for the diagnosis, classification and management of heart failure, including a discussion on the phenotypic subtypes and applicable updated treatment strategies that can help manage your patients with heart failure.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.